Kestra Medical Technologies Ltd reports results for the quarter ended April 30 - Earnings Summary

Kestra Medical Technologies

14/07/2026 22:02

Kestra Medical Technologies Ltd KMTS.OQ reported a quarterly adjusted loss of 67 cents​​ per share for the quarter ended April 30, higher than the same quarter last year, when the company reported EPS of $-2.21.  The mean expectation of seven analysts for the quarter was for a loss of 60 cents per share. Wall Street expected results to range from -63 cents to -55 cents per share.
Revenue rose 66.2% to $28.64 million from a year ago; analysts expected $26.48 million. 
Kestra Medical Technologies Ltd's reported EPS for the quarter was a loss of 67 cents​.
The company reported a quarterly loss of $38.84 million.
Kestra Medical Technologies Ltd shares had fallen by 2.7% this quarter and lost 6.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $30.00, about 17.5% above its last closing price of $24.76
This summary was machine generated from LSEG data July 14 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Apr. 30 2026 
-0.60
-0.67
Missed
Jan. 31 2026 
-0.60
-0.61
Missed
Oct. 31 2025 
-0.59
-0.64
Missed
Jul. 31 2025 
-0.76
-0.45
Beat